Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
2022-01-01 to 2022-12-31 |
As at 2022-12-31 |
As at 2021-12-31 |
|---|---|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |||
| Name of reporting entity or other means of identification |
DBV Technologies
|
— | — |
| Legal form of entity |
société anonyme à Conseil d’administration
|
— | — |
| Country of incorporation |
France
|
— | — |
| Address of entity's registered office |
|
— | — |
| Principal place of business |
aux États-Unis et en Europe
|
— | — |
| Description of nature of entity's operations and principal activities |
société biopharmaceutique spécialisée, au stade clinique, qui vise à changer le domaine de l’immunothérapie
|
— | — |
| Statement of IFRS compliance [text block] |
(International Financial Reporting Standards)
|
— | — |
| Disclosure of uncertainties of entity's ability to continue as going concern [text block] |
Si la Société ne parvient pas à atteindre ses objectifs de financement, elle pourrait être amenée à réduire ses activités,
|
— | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block] | — | — | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract] | |||
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] | |||
| Current trade receivables | — |
-
USD
|
-
USD
|
| Current trade payables | — |
14 473
USD
|
11 429
USD
|
| Explanation of sources of estimation uncertainty with significant risk of causing material adjustment |
|
— | — |